Linked Life Data

15222613

Source:http://linkedlifedata.com/resource/pubmed/id/15222613

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-6-29
pubmed:abstractText
Following recent trials, U.S (JNC7), European (ESH/ESC) and world (WHO) guidelines concerning the management of arterial essential hypertension have recently been updated. They indicate that hypertension treatment may succeed in preventing complications such as stroke or myocardial infarction. The therapeutic target is less than 140/90 mmHg (130/80 mmHg for diabetics). To reach this objective, a combination using a diuretic is required in almost all cases. Trials comparing the efficiency of "old drugs" such as diuretics or beta-blockers with "new drugs" such as ACEI or ARAII, or CCB observed minor differences in terms of cardiovascular outcomes. However, ACEI and ARAII appeared to be of particular efficiency in preventing heart and kidney failures.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0035-2640
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
626-32
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
[Influence of recent trials on essential arterial hypertension management].
pubmed:affiliation
Unité d'hypertension artérielle, Hôpital européen Georges Pompidou, 75908 Paris Cedex 15. patrick.rossignol@hop.egp.ap-hop-paris.fr
pubmed:publicationType
Journal Article, English Abstract, Review